Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicaid
Pharma
HHS provides unfavorable opinion on bluebird's fertility program
The HHS's OIG has published an unfavorable opinion on bluebird bio's fertility support program for its gene therapies.
Kevin Dunleavy
Jul 22, 2024 5:26pm
Vertex files suit against US over access to fertility program
Jul 16, 2024 7:36am
Michigan Medicaid signs deal with bluebird for SCD gene therapy
Mar 11, 2024 11:00am
Lilly ordered to pay millions more in False Claims Act case
May 10, 2023 10:24am
Bayer settles whistleblower lawsuit for $40M after 17 years
Sep 6, 2022 9:06am
Eli Lilly takes $61M hit in Medicaid whistleblower lawsuit
Aug 5, 2022 10:58am
